**Doxycycline Reduces the Risk ofC. difficileInfection in Patients Treated for Community-Acquired Pneumonia**

Watkins, Richard R. MD, MS, FACP, FIDSA, FISAC

Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH

Financial Disclosure: None of the planners or authors of this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Infectious Disease Alert 43(6):p 61-62, March 2024.

SYNOPSIS: In a retrospective study from the VA, doxycycline was associated with a lower risk of C. difficile infection compared to azithromycin in hospitalized patients with community-acquired pneumonia.

SOURCE: O'Leary AL, Chan AK, Wattengel BA, et al. Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia. Am J Infect Control 2023; Nov. 2:S0196-6553(23)00628-4. doi: 10.1016/j.ajic.2023.09.007. [Online ahead of print].